- ABOUT ME
- AREAS OF FOCUS
- EDUCATION & LEADERSHIP
- LOCATIONS & HOSPITALS
- NEWS & PUBLICATIONS
Eric Nesbit, MD finds Radiation Oncology to be a fulfilling specialty because it combines compassionate, face-to-face patient care with cutting-edge technology and anatomic problem-solving. Radiation Oncology allows him to provide personalized treatment for patients that matches their goals and values with state-of-the-art cancer care.
Dr. Nesbit is trained in specialized radiation techniques including MRI-guided radiation therapy (MRgRT) and adaptive radiotherapy, as well as stereotactic body radiation therapy (SBRT).
Dr. Nesbit grew up in the Portland area and is excited to return to the city with its incredible access to hiking, cycling, and skiing. Outside of work, he enjoys cycling, skiing, and exploring all that Portland has to offer with his wife and daughter.
Other Activities
American Society for Radiation Oncology (ASTRO)
American Board of Radiology (ABR)
American Society of Clinical Oncology (ASCO)
Areas of Focus
Head & Neck Cancer
Lung Cancer
Prostate Cancer
Central Nervous System Cancers
Gamma Knife Radiosurgery
MRI-Guided Adaptive Radiotherapy
EDUCATION & TRAINING
Radiation Oncology Residency, McGaw Medical Center of Northwestern University, 2021
Internal Medicine Internship, Providence St. Vincent Medical Center, 2017
MD, Northwestern University Feinberg School of Medicine, 2016
BA, magna cum laude, Whitman College, 2011
BOARD CERTIFICATION
Radiation Oncology
LEADERSHIP
ASTRO Member, 2017-Present
Lurie Cancer Center Scientific Review Committee, 2023-2024
HONORS
ARRO Educator of the Year, Northwestern Medicine, 2024
Outstanding Intern, Providence St. Vincent Medical Center, 2017
Eleanor R. Baldwin Scholarship, 2012-2016
Magna cum laude, Whitman College, 2011
Locations
Hospitals Served
- Providence Portland Medical Center
- Providence St. Vincent Medical Center
Publications
Naoum EG, Dorinda K, Yalamanchili A, Ho A, Yadav P, Nesbit E, Donnelly D, Kocherginsky M, Strauss J. Protons Versus Photons Postmastectomy Radiation Therapy Effects on Breast Reconstruction Outcomes and Dosimetry Analysis. Int J Radiat Oncol Biol Phys. 2025;122(2):249-266.
Nesbit EG, Gharzai LA. Take the Road Less Treated. Int J Radiat Oncol Biol Phys. 2023;115(5):1028-9.
Dajani S, Hill VB, Kalapurakal JA, Horbinski CM, Nesbit EG, Sachdev S, Yalamanchili A, Thomas TO. Imaging of GBM in the Age of Molecular Markers and MRI Guided Adaptive Radiation Therapy. Journal of Clinical Medicine. 2022 Oct 10;11(19):5961.
Rooney MK, Nesbit EG, Holliday EB, Jagsi R, Fuller CD, Ludmir EB, et al. Trends in Publication Speed of Radiation Oncology Research from 2010 to 2019. Adv Radiat Oncol. 2022;7(2):100863.
Nesbit EG, Rooney MK, Donnelly ED, Mittal BB, Sachdev S. Single Fraction Radiation for Myeloid Sarcoma Is as Effective as Multi-Fraction Regimens for Tumor Regression and Control. Clin Lymphoma Myeloma Leuk. 2021;21(10):e768-e74.
Nesbit EG, Donnelly ED, Strauss JB. Treatment Strategies for Oligometastatic Breast Cancer. Curr Treat Options Oncol. 2021;22(10):94.
Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, et al. Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient. J Clin Oncol. 2020;38(32):3773-84.
Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, et al. Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival. Neuro Oncol. 2020;22(9):1359-67.
Sperduto PW, Mesko S, Li J, et al. Beyond an updated Graded Prognostic Assessment (Breast GPA): A prognostic index and trends in treatment and survival in breast cancer brain metastases from 1985 to today. Int J Radiat Oncol Biol Phys. 2020;107(2):334-343.
Nesbit EG, Leal TA, Kruser TJ. What is the role of radiotherapy for extensive-stage small cell lung cancer in the immunotherapy era? Transl Lung Cancer Res. 2019;8(Suppl 2):s153-s162.
Varallyay CG, Nesbit E, Horvath A, et al. Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of care. J Magn Reson Imaging. 2018;48(2):441-448.
Donnelly ED, Neuschler E, Henley C, et al. Development of a nomogram to predict the clinical impact of a postexcision preirradiation mammogram. Breast J. 2018;24(4):620-623.
Varallyay CG, Nesbit E, Fu R, et al. High-resolution steady-state cerebral blood volume maps in patients with central nervous system neoplasms using ferumoxytol, a superparamagnetic iron oxide nanoparticle. J Cereb Blood Flow Metab. 2013;33(5):780-786.